Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MyStart Health vs Noom Med

MyStart Health
Graded #176

Lower grade

vs+1.4000000000000057
Noom Med
Graded #148

Higher grade

The verdict

Noom Med takes it — 68.5/100 to 67.1/100, but only just.

Noom Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Noom Med integrates GLP-1 medication access with Noom's proven cognitive behavioral therapy curriculum, 1-on-1 dietitian coaching, and dedicated care team — the most comprehensive psychology-plus-medication… MyStart Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNoom Med +42
48
90
Dose & formulationMyStart Health +43
83
40
Clinical oversightMyStart Health +7
84
77
Labs & monitoringMyStart Health +3
66
63
FulfillmentMyStart Health +5
78
73
Contract termsNoom Med +24
31
55
MyStart Health · left barNoom Med · right bar

The numbers

MetricMyStart HealthNoom Med
WeighScore67.1/10068.5/100
GradeCC
Scorecard rank#176#148
Semaglutide$299/mo (all doses, compounded)Not disclosed
Tirzepatide$299/mo (all doses, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
MyStart Health

Graded #176 · C

Strengths

  • Price Lock Guarantee — your $299 base rate doesn't rise as your dose escalates
  • Fast onboarding: roughly 5-minute intake, 24-hour prescription turnaround, 2–4 day shipping
  • 24/7 care team access with unlimited clinician messaging included
  • LegitScript certified
  • Clear Section 503A compounding disclosure on every landing page

Where it loses points

  • Not BBB accredited — C+ rating with 10 complaints, mostly shipping delays and support access
  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Markets oral tirzepatide, but no FDA-approved oral tirzepatide exists
  • Very new company (incorporated May 2024) with a limited track record
  • Pharmacy partners not named, so 503A compliance can't be independently verified
Noom Med

Graded #148 · C

Strengths

  • Combines GLP-1 medication with CBT behavior change
  • Dedicated dietitian included in every plan
  • Highest support score in fitness app category
  • Integrated care team for medication and coaching
  • Noom's proven behavioral curriculum

Where it loses points

  • Available in only 40 states — excludes AK, HI, ID, MT, NM, SD, VT, WV, WY, ND
  • More expensive than app-only alternatives
  • Requires commitment to both medication and coaching program

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard